Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
42.4 EUR | -0.93% | -0.47% | -0.47% |
Sales 2023 * | 568M 612M | Sales 2024 * | 636M 686M | Capitalization | 1.37B 1.48B |
---|---|---|---|---|---|
Net income 2023 * | -74M -79.82M | Net income 2024 * | -4M -4.31M | EV / Sales 2023 * | 3.49 x |
Net Debt 2023 * | 615M 663M | Net Debt 2024 * | 661M 713M | EV / Sales 2024 * | 3.19 x |
P/E ratio 2023 * |
-14.4
x | P/E ratio 2024 * |
-265
x | Employees | 2,228 |
Yield 2023 * |
0.07% | Yield 2024 * |
0.07% | Free-Float | 29.83% |
Latest transcript on Biotest AG
1 day | -1.64% | ||
1 week | -0.47% | ||
Current month | +0.47% | ||
1 month | +0.47% | ||
3 months | -0.47% | ||
6 months | -0.93% | ||
Current year | -0.47% |
Date | Price | Change | Volume |
---|---|---|---|
24-03-28 | 42.4 | -0.93% | 0 |
24-03-27 | 42.8 | +0.47% | 10 |
24-03-26 | 42.6 | 0.00% | 10 |
24-03-25 | 42.6 | 0.00% | 10 |
24-03-22 | 42.6 | 0.00% | 182 |
Delayed Quote Xetra, March 28, 2024 at 12:36 pm EDT
More quotesEPS Revisions
Annual profits - Rate of surprise
1st Jan change | Capi. | |
---|---|---|
+0.44% | 90.27B | |
+9.61% | 44.05B | |
-16.67% | 31.45B | |
+44.99% | 23.35B | |
-9.41% | 16.72B | |
-25.92% | 15.09B | |
-9.27% | 12.82B | |
-7.57% | 11.95B | |
+0.07% | 8.71B |
- Stock
- Equities
- Stock Biotest AG
- Stock Biotest AG - Xetra